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The Physiologic Role of CD19 Cytoplasmic Tyrosines
to increased calcium release and activation of the ERK,Yue Wang,1 Stephen R. Brooks,1
Xiaoli Li,2 Amy N. Anzelon,4 JNK, and p38 Mitogen Activated Protein Kinase paths
(Li and Carter, 1998; Li et al., 1997; O’Rourke et al.,Robert C. Rickert,4 and Robert H. Carter1,2,3,5
1Department of Microbiology 1998).
Specific cytoplasmic molecules bind to particular2 Department of Medicine
University of Alabama at Birmingham CD19 phosphotyrosines (Figure 1A). The most mem-
brane-proximal tyrosine in the linear sequence, Y3303 The Birmingham VA Medical Center
Birmingham, Alabama 35294 (YGNV), binds Grb2 and, probably indirectly, SOS. CD19
Y391 and Y421 (YEEP and YENP) bind Vav and Phospho-4 Division of Biology and UCSD Cancer Center
University of California, San Diego lipase-C2 (Brooks et al., 2000). Y403 (YEND) and Y443
(YENE in human, YENA in mouse) have been found byLa Jolla, California 92093
others to bind Fyn and/or Lyn (Chalupny et al., 1995;
Fujimoto et al., 2000). Two tyrosines, Y482 and Y513
(YDEM and YENM), are required for binding of Phospha-Summary
tidylinositol 3-kinase (PI3K) (Tuveson et al., 1993).
How these associations mediate CD19 function hasThe physiologic role of eight CD19 tyrosines was ex-
amined in CD19-knockout mice expressing transgenic been controversial. We found that PI3K activity was re-
quired for normal CD19 function in primary human BCD19 constructs. CD19 Y482 and Y513 were essential
for normal B cell biology, including differentiation of cells, while CD19 Y391 appeared more important for
calcium and ERK responses in transfected Daudi lymph-B1 and marginal zone B cells and for T-dependent
and -independent antibody responses. In immunized oblastoid cells (Brooks et al., 2000; Li and Carter, 2000).
Cambier and coworkers found that the association ofmice with mutations in CD19 Y482 and Y513, early
germinal center B cells appeared normal in phenotype PI3K with CD19 Y482 and Y513 was important for activa-
tion of calcium release by the BCR in transfected plas-and number, but maturation in the germinal center
was defective. This was associated with retarded pro- macytoma cells (Buhl and Cambier, 1999; Buhl et al.,
1997). Tedder and coworkers found that the binding ofgression through the cell cycle. Thus, Y482 and Y513
are essential for all functions of CD19 in vivo. Mutation Lyn to phosphorylated Y482 and Y513 lead to activation
of the kinase and phosphorylation of downstream sub-of these reduces proliferation in germinal center B
cells, providing a potential mechanism for the failure strates (Fujimoto et al., 2000). However, the relevance of
these studies to the biology of B cells in vivo is unknown.of maturation, which abrogates antibody responses.
We developed a transgenic system to determine the
physiologic role of CD19 tyrosines in vivo. CD19/Introduction
mice were reconstituted with CD19 transgenes that were
either wild-type (WT) or that contained mutations in pairsCD19 is required for normal B cell responses in mice
and is likely to play a regulatory, and perhaps patho- of cytoplasmic tyrosines with matched function or motif.
These transgenes differ from those previously reportedgenic, role in human disease. The peritoneal B1 and the
splenic marginal zone subsets of B cells are absent in in that they contain a murine genomic sequence encod-
ing the extracellular, transmembrane, and the initial cy-mice deficient in CD19 (Engel et al., 1995; Martin and
Kearney, 2000a; Rickert et al., 1995; Sato et al., 1995). toplasmic exons (Figure 1B). We linked to this the human
cDNA sequences encoding the remaining portion of theThe IgG antibody (Ab) response to protein antigens is
dramatically reduced in these animals, with a commen- cytoplasmic domain, which we had previously ex-
pressed and tested in cell lines (Brooks et al., 2000; Lisurate reduction in number and size of germinal centers
(Fearon and Carroll, 2000). Conversely, overexpression et al., 1997). This created a system in which full-length,
mutant CD19 is situated in its normal molecular contextof CD19 has been associated with autoimmunity (Tedder
et al., 1997). Abnormalities in CD19 expression have and appropriate cellular environment for interaction. We
now report the essential biologic functions of eight CD19been reported in the human autoimmune disease sclero-
derma (Sato et al., 2000). Thus, knowledge of CD19 tyrosines in B cell differentiation and Ab responses. In
addition, analysis of the role of these tyrosines in thefunction is important for understanding both basic and
applied immunity. germinal center reaction demonstrated that normal tran-
sition through the cell cycle was dependent on CD19The CD19 cytoplasmic domain contains nine evolu-
tionarily conserved tyrosine residues (Tedder and function, providing an explanation for the requirement
for CD19 in the Ab response to T-dependent antigens.Isaacs, 1989). CD19 is rapidly phosphorylated following
ligation of the B cell antigen receptor (BCR). The phos-
phorylated tyrosines provide binding sites for the SH2- Results
domains of cytosolic proteins (Brooks et al., 2000).
These associations link CD19, either by itself or in con- Expression of CD19 Transgenes
junction with the BCR, to downstream signals that lead For each transgene, two founder lines with appropriate
expression of CD19 were selected for further analysis.
Expression of CD19 in bone marrow, thymus, lymph5 Correspondence: rcarter@uab.edu
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Figure 1. CD19 Cytoplasmic Domain, Transgene Construction, and Expression
(A) CD19 cytoplasmic exons and tyrosines are represented above and below the line, respectively, and the principal associations are indicated
by arrows: ecto, extracellular; TM, transmembrane; cyto, cytoplasmic.
(B) Transgenes contained murine CD19 genomic sequence connected to the human cDNA corresponding to exons 7–15.
(C) Flow cytometric analysis of cell surface expression of CD19 and B220 on splenic mononuclear cells from the indicated mice. The numbers
represent the mean fluorescence channel for CD19.
nodes, and spleen in these mice was limited to B cells and CD19/ mice. Results from mice from different
founder lines with the same transgene were equivalent,(Figure 1C and data not shown). Percentages of B cells
in these compartments were similar to those in mice and the results for only one founder line for each trans-
gene are shown.with native CD19. We obtained lines for each transgene
in which the expression level of surface CD19 was signif-
icantly greater than that in CD19/ mice and which Function of CD19 Tyrosines in B Cell Differentiation
To determine the role of CD19 tyrosines in vivo, weapproached that in CD19/mice. Mice expressing the
Y403F/Y443F transgene contained some B cells with compared B cell differentiation in mice expressing the
different transgene products on the CD19-knockoutlower CD19 expression (Figure 1C), but this did not ap-
pear to alter B cell function (see below). In our in vivo background. Marginal zone B cells were absent in the
CD19/ 129Sv/J mice, in agreement with previousexperiments, B cell function was equivalent in CD19/
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results in C57Bl/6 mice (Martin and Kearney, 2000a). The CD19 is required for IgG Ab responses to T-dependent
percentages of marginal zone B cells (CD21highCD23low) antigens. To determine whether CD19 tyrosines are in-
in CD19/ mice transgenic for CD19 Y330F/Y360F, volved in this process, mice were challenged with 50 g
Y391F/Y421F, or Y403F/Y443F were similar to CD19/ alum-absorbed 4-hydroxy-3-nitrophenylacetyl chicken-
mice. In contrast, in the Y482F/Y513F mice, the number -globulin (NP(21)-CGG) and boosted at day 28 with 50
of marginal zone cells (0.23%) was equivalent to the g of NP(21)-CGG in buffered saline. CD19/ mice
number in CD19/ mice (0.44%) (Figure 2A). Similar had robust responses as judged by the serum IgM and
results were found using IgD and CD1 to label marginal IgG1 anti-NP specific Ab titers, particularly after rechal-
zone B cells, so as to exclude transitional cells (data lenge at day 28 (Figures 3D and 3E). Y330F/Y360F,
not shown). Y391F/Y421F, and Y403F/Y443F mice mounted primary
Splenic tissue sections were examined to confirm the and secondary T-dependent Ab responses with a time
loss of marginal zone cells observed by flow cytometry. course and magnitude comparable to those of
The marginal zone B cells appear histologically as a rim CD19/ mice. The IgM responses to NP-CGG were
of IgM cells (green in Figure 2B) outside the marginal significantly lower in CD19/ mice and CD19 Y482F/
sinuses (identified by the presence of marginal sinus Y513F mice, at all time points examined (Figure 3D).
macrophages that stain with MOMA-1 [blue in Figure During the first 3–4 weeks, small but detectable IgG1
2B]). Consistent with the results of the phenotypic analy- responses were observed in CD19/ mice and CD19
sis, the marginal zone cells were essentially absent in Y482F/Y513F mice, but at lower absolute levels than in
the CD19/ mice. These cells were fully rescued by CD19/mice or the other transgenic mice (Figure 3E).
the presence of an unmutated, WT CD19 transgene. In However, after rechallenge at 4 weeks, the serum levels
contrast, the Y482F/Y513F transgene completely failed of IgG1 in CD19/ mice and Y482F/Y513F mice de-
to rescue the marginal zone B cells. The histology in the creased, in contrast to the increasing titers observed in
Y482F/Y513F mice was equivalent to that in CD19/ CD19/ and other transgenic mice. Thus, CD19 Y482
mice. Thus CD19 Y482 and/or Y513 are required for the and/or Y513 are required for IgM and primary and sec-
generation and/or maintenance of marginal zone B cells, ondary IgG responses to NP.
by both anatomical and phenotypic analysis.
A second developmental defect in CD19/ mice is Function of CD19 Tyrosines in the Germinal
their inability to generate stable peritoneal B1 cells (En- Center Reaction
gel et al., 1995; Rickert et al., 1995). To determine which Reduced number and size of germinal centers in CD19-
CD19 tyrosines mediate B1 cell development, we ana- deficient mice have been previously reported (Rickert
lyzed peritoneal mononuclear cells from mice by flow et al., 1995). A similar reduction was observed in histo-
cytometry. B1a cells (CD5IgM, Figure 2C) and total B1 logical studies of spleens of Y482F/Y513F transgenic
cells (Mac-1IgM, Figure 2D) were similar in CD19/ mice after challenge with NP-CGG (data not shown).
mice and in CD19-knockout mice expressing the Y330F/ In B lymphocytes, binding of Peanut Agglutinin (PNA)
Y360F, Y391F/Y421F, or Y403F/Y443F transgene. How- localizes to germinal centers and PNA B cells express
ever, both populations were almost absent in CD19/
other markers that identify them as germinal center B
mice. The percentage of B1 cells in the CD19 Y482F/
cells, including GL-7 and Fas (Shinall et al., 2000). At
Y513F transgenic mice was equivalent to that in
day 7 after immunization with sheep red blood cellsCD19/ mice. Thus, the differentiation and/or survival
(SRBC), 25% of B220 splenic lymphocytes in CD19/of B1 cells, like that of marginal zone B cells, is depen-
mice bound PNA. A similar percentage of splenic lym-dent on CD19 Y482 and/or Y513.
phocytes was B220PNA in Y330F/Y360F, Y391F/
Y421F, and Y403F/Y443F transgenic mice. In contrast,Function of CD19 Tyrosines in Ab Responses
the percentage dropped by 10-fold (2.4% of B220 cells)The Ab responses to T-independent type 2 antigens
in CD19/ mice (Figure 4A). A similar reduction of atwere diminished in CD19-deficient mice when the anti-
least 80%, compared to CD19/ mice, was apparentgen was presented at lower epitope density, consistent
at day 4 and persisted through day 14 in the CD19/with the requirement for CD19 for similar Ab responses
mice, although the absolute number of PNA cells in-in B cells with lower-affinity BCR (Shih et al., 2002) (Fig-
creased over this period in both normal and CD19-defi-ure 3). To determine which CD19 tyrosines are required
cient mice (not shown). Less than 2% of total splenicfor this response, mice were challenged with either
lymphocytes were PNA in CD19 Y482F/Y513F trans-phosphorylcholine (PC)-Ficoll (Figure 3A) or trinitrophe-
genic mice, similar to the CD19/ mice. However, thenyl (TNP)(6)-Ficoll (Figures 3B and 3C), and specific IgM
number of PNA B cells was consistently greater in(Figures 3A and 3B) and IgG3 (Figure 3C) responses
Y482F/Y513F transgenic mice (4.4% of B220 cells inwere measured. Little or no response was observed in
Figure 4A) than in CD19/ mice (2.4% of B220 cellsthe CD19-deficient mice, and the Y482F/Y513F mice
in Figure 4A). These results demonstrate that Y482 andwere similar. A response was observed in CD19/
Y513 are required for the normal development of germi-mice and in mice with all other transgenes, in both IgM
nal center B cells. They also provide evidence for a CD19and IgG3. Although there was significant variability in
function in the response to a strong antigenic stimulusthe level of antibodies in individual experiments in the
in vivo that is independent of Y482 and Y513.Y330F/Y360F, Y391F/Y421F, and Y403F/Y443F mice, as
To examine the role of CD19 tyrosines in the differenti-illustrated in Figure 3, among all transgenic mice, only
ation of responding cells, we used flow cytometry, gat-Y482F/Y513F mice had consistently diminished IgM re-
ing on B220 cells, to measure the expression of CD38sponses to both PC and TNP and reduced IgG3 re-
sponse to TNP in all experiments. on B cells. CD38 is downregulated in B cells undergoing
Immunity
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differentiation in the germinal center reaction in the differentiation and class switching in germinal center
B cells are dependent on CD19 Y482 and Y513. Themouse (Oliver et al., 1997; Shinall et al., 2000). At day 7
after challenge with SRBC, most of PNA B cells in correlation of the reduction in the CD38low cells with
diminished Ab responses suggests that maturation inCD19/ mice were CD38 (Figure 4B). The percent-
ages of PNA, CD38low cells were normal in the Y330F/ the germinal center reaction is required for normal pro-
duction of IgM as well as IgG1 antibodies.Y360F, Y391F/Y421F, and Y403F/Y443F mice. In con-
trast, the percentage of PNA, CD38low cells was dimin- Binding of labeled NP was analyzed to explore the
further differentiation of antigen-specific B cells follow-ished in the CD19/ and Y482F/Y513F mice. Thus,
there was a defect in maturation of germinal center B ing immunization with NP-CGG. Specific responding
cells in the latter stages of the germinal center reactioncells in these mice.
To confirm these results in a second system, we ana- can be identified as NP, IgD (Driver et al., 2001; Jacob
et al., 1993), which were apparent only after immuniza-lyzed the induction of germinal center B cells in mice
immunized with NP-CGG. Although reduced in number tion (Figure 5A). There were fewer responding cells in
the CD19/ and Y482F/Y513F mice than in CD19/by about 75%, compared to the SRBC system, PNA,
B220 germinal center B cells were easily detectable mice. We further characterized these cells on the basis
of expression of B220 and CD138 (McHeyzer-Williamsand were analyzed for percentages (Figures 4C and 4D)
and absolute numbers (Figure 4E) of subsets. At day 7 et al., 2000). In the CD19/, CD19/, and Y482F/
Y513F mice, the B220, CD138 subset was the mostafter immunization with NP, the total number of PNA,
B220 cells was reduced by approximately 50% in abundant, but the percentages (Figure 5B) and absolute
numbers (Figure 5C) of these cells were reduced in theCD19/ and Y482F/Y513F mice (although no differ-
ence was apparent between these two after NP immuni- knockout and mutant transgene mice. The reduction
was apparent 4 days after immunization and persistedzation, likely as a function of the weaker antigen). To
examine the differentiation of germinal center B cells in until 56 days. In the NP, IgD, B220 subset, the num-
bers of cells expressing IgM or IgG1 were greatly dimin-this system, we analyzed expression of CD38 and IgD,
which are also downregulated in the germinal center ished (Figure 5D). These results confirm the loss of anti-
gen-specific, differentiated germinal center cells in micereaction (Figure 5C). When normalized to equal numbers
of PNA, B220 cells, the percentage of early germinal with defective CD19 function.
When normalized to equal numbers of NP, IgD cells,center cells (CD38, IgD) was increased in the mice
with defective CD19, such that the absolute numbers the percentage of these cells that express CD138 was
decreased by about 50% in the CD19/ and Y482F/(Figure 5E) of these cells were only minimally reduced
compared to mice with normal CD19. However, the per- Y513F mice compared to CD19/ mice (Figure 5B).
The decrease in the CD138 cells, which are Ab-secre-centages of cells that have progressed further in the
germinal center reaction (CD38, IgD) were reduced in ting cells or their precursors, was consistent with the
decrease in serum anti-NP Ab levels after immunizationmice with defective CD19. These results suggest that,
although B cells can be activated, they are unable to in these mice. In contrast, the percentages of B220,
CD138 cells were increased in the knockout andprogress to later stages in the germinal center reaction
when CD19 function is defective. Y482F/Y513F mice (Figure 5B), such that the absolute
numbers were unchanged from normal mice (data notIgM and IgG1 are the predominant isotypes in germi-
nal center B cells responding to NP (Driver et al., 2001). shown). As in previous publications (McHeyzer-Williams
et al., 2000), these cells had surface  light chain, andWhen normalized to equal numbers of PNA, B220
cells, a high percentage of CD38, IgM cells was pres- approximately half were IgE in all mice tested (not
shown). NP binding cells were also examined in the boneent in the CD19/ and Y482F/Y513F mice, compared
to CD19/ mice, but the number of CD38, IgM cells marrow of mice with altered CD19 after immunization
with NP-CGG. At 7 days, the differences were relativelywas significantly reduced (Figure 4D, top panels). IgG1-
expressing B220, PNA cells were abundant in minor, but at 21 days the number of such cells was
reduced by more than 50% in the bone marrow ofCD19/ mice, and most of these were CD38low. In the
CD19/ and Y482F/Y513F mice, switched cells were CD19/ and Y482F/Y513F mice, compared to
CD19/ mice. The percentages of subsets were simi-present, but the percentage was reduced by over 70%
(Figure 4D, bottom panels). Furthermore, most of the lar to the spleen (not shown).
To determine why the number of germinal center cellsswitched cells were CD38high in these mice. The absolute
numbers of CD38low germinal center B cells expressing was reduced in mice with defective CD19, we analyzed
the effects of CD19 on cell cycling. The number of cellseither IgM or IgG1 were reduced by an order of magni-
tude in these mice (Figure 4E, bottom panels). Thus, both entering S phase was measured after a 2–3 hr in vivo
Figure 2. Normal B Cell Differentiation Requires CD19 Y482 and/or Y513
(A) Splenic mononuclear cells were stained with CD21 and CD23. The cells corresponding to marginal zone (CD21highCD23neg) and follicular
(CD21intermediateCD23high) B cells are labeled red and blue, respectively. The numbers indicate the proportion of the total population within the
regions shown.
(B) Spleen sections from the indicated mice were stained for B cells (anti-IgM, green), T cells (anti-CD4 and anti-CD8, red), and marginal sinus
metallophilic macrophages (MOMA-1, blue; original magnification, 100).
(C and D) Peritoneal cells from the indicated mice were stained with antibodies to (C) CD5 and IgM, to analyze B1a cells, and (D) Mac-1and
IgM for total B1 cells.
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Figure 3. CD19 Y482 and/or Y513 Are Required for Normal Ab Responses
Mice with the indicated CD19 genes were immunized (arrows) with the T-independent type 2 antigens phosphorylcholine (PC)-ficoll (A) or
TNP-ficoll (B and C) on day 0, or with the T-dependent antigen NP-CGG in alum on day 0 and boosted with the same antigen in PBS on day
28 (D and E). Serum was obtained on the days indicated, and specific IgM (A, B, and D), IgG3 (C), or IgG1 (E) Ab levels were measured by
ELISA. The results are expressed as relative units, by comparison to standard sera as described in Experimental Procedures. Stars (D and
E) represent statistically significant difference (p  .05) compared to CD19/ mice.
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Figure 4. The Role of CD19 Tyrosines in the Germinal Center Reaction
Mice with the indicated CD19 genes were immunized with SRBC (A and B) or NP-CGG (C–E). Splenic mononuclear cells were obtained on
day 7 except as indicated.
(A) The number of PNAB220 cells was reduced in Y482F/Y513F transgenic mice, compared to mice with other mutant CD19 transgenes or
to CD19/ mice, but was greater than the number in CD19/ mice.
(B) Analysis of expression of CD38 and binding of PNA in B220 cells.
(C–E) After immunization with NP-CGG, splenic B220, PNA mononuclear cells were further analyzed for expression of surface CD38 and
IgD (C), IgM (D, top), and IgG1 (D, bottom). The absolute number of cells was calculated (E).
Immunity
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Figure 5. CD19 Y482 and Y513 Are Important in the Differentiation of Antigen-Specific Germinal Center B Cells
Spleen mononuclear cells were isolated from mice with the indicated CD19 genes after immunization with NP-CGG in alum at 7 days after
immunization except as indicated.
(A) NP binding, IgDlow cells appeared only in immunized mice, but the percentage was reduced in CD19/ and Y482F/Y513F mice.
(B) For each type of mice, the percentages of the NPIgD cells in the B220CD138, B220CD138, and B220/CD138 subsets were
determined by staining with anti-B220 and anti-CD138.
(C) The absolute numbers of total NP, IgD lymphocytes (left panel) or of the B220, CD138 (middle), or B220, CD138 (right) subsets of
these cells were calculated from flow cytometric analysis. The numbers of the NP, IgD, B220/, CD138 subset were not different between
the mice lines.
(D) Ig class expression on the NP, IgD, B220 cells was analyzed, and the numbers of cells for each isotype were calculated. Cells expressing
IgA, IgE, or IgG3 were detectable but sparse.
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Figure 6. CD19 Y482 and Y513 Are Required
for Normal Cycling of Germinal Center B Cells
On day 7 after immunization with SRBC,
CD19/, or Y482/513F, mice were injected
with Brdu 3 hr before sacrifice and isolation
of T cell-depleted splenocytes. The remaining
cells were analyzed for extracellular Fas, in-
tracellular IgM and Brdu, and for DNA content
with 7-AAD. The incorporated Brdu and DNA
content were used to determine the percent-
ages of cells that had been in S phase in
the presence of Brdu in vivo (Brdu) or were
Brdu and diploid (7-AADlow) or tetraploid
(7-AADhigh) in the IgMFas, IgMFas, and
total Fas subsets.
exposure to Brdu on day 7 after immunization with and Y482F/Y513F transgenic mice and stimulated with
PBS alone or with anti-IgM for 1 min and lysed. CD19SRBC. Preliminary experiments consistently demon-
strated a reduction in the percentage of Brdu B cells was immunoprecipitated and eluates were immunoblot-
ted with anti-phosphotyrosine. In B cells from Y482F/in the CD19/ and Y482F/Y513F mice, compared to
CD19/mice (data not shown). To measure cell prolif- Y513F mice, anti-IgM induced a 3.4-fold increase in tyro-
sine phosphorylation of CD19 at 1 min, which persistederation in germinal center B cells, T cells were depleted,
and the remaining cells were stained for cell surface for 10 min, compared to the 9-fold increase observed in
the CD19 from CD19/ mice (Figure 7A). The increaseFas (which correlated precisely with PNA cells in our
analysis of induction of germinal center B cells) and observed in the transgenic mice represents 50% of what
one would predict from the loss of two of nine tyrosines,intracellular IgM. Anti-Brdu and 7-AAD binding were
analyzed on Fas, IgM (resting) cells, or Fas, IgM if all were phosphorylated equivalently.
To test the ability of a stronger stimulus to induce(responding, unswitched) cells, or Fas, IgM (all re-
sponding cells) (Figure 6). Few of the resting cells, as phosphorylation of the remaining tyrosines, pervana-
date, a phosphatase inhibitor, was used to maximallyexpected, had incorporated Brdu, and their DNA was
diploid, consistent with G0/G1 phase cells. In the re- phosphorylate tyrosines other than Y482 and Y513 on
the mutant CD19. After pervanadate treatment, tyrosinesponding cells, when normalized to the same number
of Fas cells, approximately 1/3 as many cells had en- phosphorylation of CD19 from Y482F/Y513F transgenic
mice was detectable, consistent with the presence oftered S phase during the period of exposure to Brdu in
the Y482F/Y513F mice, compared to wild-type mice. additional, available tyrosines (Figure 7B). However, the
level of phosphorylation remained significantly de-Similar results were observed at different days after
SRBC immunization and after different lengths of expo- creased, compared to native CD19 from CD19/mice.
Reprobing with anti-CD19 demonstrated equivalent losssure to Brdu. Thus, we consistently observed a decrease
in the percentage of germinal center B cells entering S of recovery of wild-type and mutant CD19 after pervana-
phase in mice with defective CD19. The diminution in date treatment. Probes of anti-CD19 precipitates from
the number of cells transitioning through the cell cycle pervanadate-treated B cells expressing the mutant
provides a mechanism for the reduction in the number CD19 revealed a loss of both basal and activation-
of germinal center cells in these mice. induced association with PI3K. Thus, tyrosine phosphor-
ylation of CD19 was reduced but not blocked in Y482F/
Y513F transgenic mice, and these two residues wereDecreased Phosphorylation of CD19 Y482F/Y513F
required for the association of CD19 with PI3K in primaryin Primary B Cells after BCR Ligation
B cells.To determine why mutation of Y482 and Y513, which
are only two of the nine CD19 cytoplasmic tyrosines,
Role of CD19 Y482 and Y513 in Calcium Responsesrendered the entire molecule functionally crippled, we
Calcium responses were equivalent in B cells fromexamined their effect on phosphorylation of the re-
CD19/, CD19/, and Y482F/Y513F mice stimu-maining tyrosines. B cells were isolated from CD19/
Immunity
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Figure 7. Role of CD19 Y482 and Y513 in Ty-
rosine Phosphorylation and Calcium Re-
sponses
(A and B) Splenic B cells were isolated from
the indicated mice and either incubated with
PBS or stimulated with F(ab) 2 anti-IgM for
the indicated times (A) or with pervanadate
(B) before lysis. CD19 was immunoprecipi-
tated, resolved by SDS-PAGE, and probed
with anti-phosphotyrosine, then sequentially
stripped and reprobed with anti-PI3K p85 and
anti-CD19. The blot in (B) also contains
whole-cell lysate from unstimulated cells,
probed with anti-PI3K p85.
(C) Changes in intracellular free calcium con-
centrations were measured in B cells from
CD19/ mice (triangles), CD19 Y482F/
Y513F transgenic mice (squares), or
CD19/ mice (diamonds) after stimulation
with 1 or 5 g/ml F(ab)2 goat anti-mouse IgM
alone, or 1 g/ml F(ab)2 rabbit anti-mouse
IgG(HL) alone, or 1 g/ml F(ab)2 goat anti-
mouse IgM and 5g/ml 1D3 anti-CD19 simul-
taneously. Antibodies were added after a
20 s baseline (arrows).
enhancement of the calcium response was dependentlated with 0.5–20 g/ml anti-IgM (Figure 7C and data
on CD19 Y482 and/or Y513 (Figure 7E) (no increase wasnot shown). The pattern of whole-cell tyrosine phosphor-
observed with 1D3 anti-CD19 alone at these concentra-ylation, CD22 tyrosine phosphorylation, and phosphory-
tions). In summary, the analysis of calcium demon-lation of Akt were all equivalent (data not shown), in
strates BCR-dependent signaling that is CD19 indepen-contrast to some but not all previous reports (Buhl and
dent (anti-IgM alone), or dependent on CD19 but not onCambier, 1999; Fujimoto et al., 1998). The calcium re-
CD19 Y482 or Y513 (anti-IgG(H&L)), or that is dependentsponse after crosslinking CD19 with biotinylated 1D3
on these two tyrosines (anti-IgManti-CD19), sug-and the enhanced calcium response and activation of
gesting differential requirements for CD19 in differentERK after co-crosslinking IgM and CD19 were equiva-
BCR-dependent stimuli. This provides an in vitro corre-lent in B cells from CD19/ and Y482F/Y513F mice
late for the differences observed in the total number of(not shown). However, the calcium response was dimin-
germinal center B cells in CD19/, CD19/, andished in B cells from CD19-deficient mice when stimu-
Y482F/Y513F mice after SRBC immunization.lated with an anti-IgG that recognizes immunoglobulin
heavy and light chain, as previously described (Buhl and
Cambier, 1999). Nevertheless, with this Ab the calcium Discussion
response in B cells from Y482F/Y513F transgenic mice
was equivalent to that in cells from CD19/ mice, We used CD19 transgenes, driven by the native pro-
moter, to express altered CD19 in otherwise CD19-defi-indicating that in primary cells, unlike J558L cells, the
defect in calcium responses following stimulation with cient mice. This resulted in CD19 expression on appro-
priate cell types at levels comparable to native CD19.this Ab is dependent on CD19 but not on CD19 Y482 or
Y513 (Figure 7D). Simultaneous addition of anti-IgM and We demonstrate that two CD19 tyrosines, Y482 and
Y513, together are essential for all known functions ofanti-CD19 results in an enhancement of calcium re-
sponses (Fujimoto et al., 2001). With this system, the CD19. In contrast, each of the six other tyrosines tested
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in this system is dispensable for normal B cell differentia- mately 50% (i.e., to a greater degree than one would
expect simply from loss of two of the nine tyrosines).tion and antigen responsiveness. This result now pro-
vides a benchmark against which all in vitro studies of Thus, these two tyrosines are not required for phosphor-
ylation of others on CD19, but either they regulate phos-CD19 signal transduction must be measured.
A remarkable property of CD19 Y482 and Y513 is that phorylation of other sites or they are the predominant
sites of tyrosine phosphorylation in primary cells. How-they contribute to all aspects of CD19 function. Mutation
of these two tyrosines disrupts CD19 function in B cell ever, in contrast to work in CD19 knockouts on the
C57Bl6 background (Fujimoto et al., 1999), we observedifferentiation, with near complete loss of peritoneal B1
cells and of splenic marginal zone B cells. In addition, no differences in phosphorylation of other molecules
after stimulation with anti-IgM, including Vav, Lyn, andboth T-dependent and T-independent Ab responses are
abrogated in mice expressing these mutations. This re- CD22, or in the pattern of tyrosine-phosphorylated mole-
cules in whole-cell lysates, in B cells from either Y482F/sult contrasts with the partial physiologic consequences
of mutation of cytoplasmic tyrosines in Ig	 and CD28. Y513F or CD19/mice, compared to B cells from mice
with normal CD19 (Y.W. and R.H.C., unpublished data).In the former, mice expressing mutations in the immune
receptor tyrosine-based activation motif tyrosines re- Furthermore, the phenotype of mice deficient in Lyn,
which includes autoimmunity and expansion of the B1tained partial function unless crossed with the Ig

knockout (Kraus et al., 2001). Similarly, mutation of the subset, is different than that of CD19/ mice, sug-
gesting alternate signaling pathways. Thus, while Lyntyrosine in CD28 that binds PI3K had an effect on a
survival signal but not on coactivation (Okkenhaug et may be an important upstream element in CD19 phos-
phorylation (Fujimoto et al., 2000), our results suggestal., 2001). Unlike the tyrosine(s) in Ig	 and CD28, point
mutation in CD19 Y482 and Y513 results in mice that, that failure to activate Lyn is not the primary defect in
Y482F/Y513F mice.in terms of differentiation of stable populations of cells
and of Ab responses, are equivalent to CD19-deficient The association of CD19 with PI3K is completely
blocked in Y482F/Y513F mice. Previously publishedmice.
Some of the physiologic results of mutation of Y482 studies on Akt and Btk in the CD19/, 129Sv/J mice
support a role for PI3K in CD19 function (Buhl et al.,and Y513 or of CD19 deficiency may be a consequence
of other defects in these mice. The lack of B1 and mar- 1997; Otero et al., 2001). However, our studies of calcium
signaling demonstrate that the mechanism by whichginal zone B cells leads to reduced serum IgM, and the
“natural” IgM produced by these cells may be important CD19 signals is strikingly dependent on the system used
to aggregate the BCR or CD19, so the studies of signal-for priming other responses (Martin and Kearney,
2000b). The marginal zone B cells produce a rapid initial ing ex vivo must be interpreted with caution. B cell devel-
opmental and functional defects in p85/ and Btk/response to T-independent antigen and present antigen
to T cells (Oliver et al., 1999). However, T-dependent Ab mice are similar to but more severe than those of
CD19/mice (Fruman et al., 1999; Suzuki et al., 1999).responses are normal in mice deficient in pyk-2 and
Notch-RBP-J, despite the lack of marginal zone B cells This suggests that CD19 functions via these pathways,
but that CD19-independent mechanisms of activation(Guinamard et al., 2000; Tanigaki et al., 2002). Thus,
these responses, particularly after the first few days of these pathways, such as through BCAP, also exist
(Okada et al., 2000). Indeed, activation of Akt remains(Martin et al., 2001), are likely to be directly dependent
on CD19 signaling. at least partially inducible in CD19-defective mice, con-
sistent with other mechanisms of activation of PI3K inNo essential biologic role was discernable for CD19
Y330, Y360, Y391, Y403, Y421, or Y443. This is surpris- these mice (Otero et al., 2001). We suspect that the
localization function of binding of PI3K to CD19, perhapsing, given the evolutionary conservation of these resi-
dues and the flanking amino acids and our previous in lipid microdomains (Cherukuri et al., 2001), is critical.
CD19 Y482 and/or Y513 are critical for the differentia-finding of a role for Y330 and Y391 in CD19 signaling in
Daudi cells. However, the studies of calcium responses tion of germinal center B cells. Although the total number
of germinal center, PNA cells is reduced in CD19/and the differences in the number of PNA cells induced
by SRBC challenge suggest CD19 signaling that is inde- and Y482F/Y513F mice, the number of CD38, early
germinal center cells is little changed. In certain aspects,pendent of Y482 and Y513 in vitro and in vivo. These
observations suggest that Y482 and Y513 are not the such as expression of Fas and binding PNA, the cells
that are induced to enter the germinal center reactiononly means of signaling by CD19 in primary mouse B
cells. Possible mechanisms for this additional signaling in these mice are qualitatively normal. Thus, the initial
activation of responding cells shows little dependenceinclude redundant pathway(s) linked to multiple tyro-
sines other than Y482 and Y513, or the single untested on CD19. However, a partial block occurs at the transi-
tion to the later stages in the germinal center reaction.CD19 tyrosine, Y490, or non-tyrosine-based signaling
by the CD19 cytoplasmic domain. In addition, the trans- The reduction in the number of CD38low, IgD, B220,
IgM cells correlates with the reduced serum IgM re-membrane and extracellular domains of CD19 are suffi-
cient to promote interactions with CD21 and CD81, sponse to NP. This suggests that differentiation of IgM
cells in germinal centers to the CD38low, IgD stage maywhich could signal through other means (Matsumoto et
al., 1993). However, this alternative signal is not suffi- be required for serum IgM responses to T-dependent
antigens (after the contribution of more rapid respond-cient to rescue normal B cell differentiation or Ab re-
sponses. ers, such as marginal zone cells). Class switching is also
diminished in the Y482F/Y513F and CD19/ mice. InTyrosine phosphorylation of CD19 with mutations in
Y482 and Y513F is rapid and easily detectable, but, these mice, the switched cells are predominantly
CD38. Thus, switching can occur without downregula-compared to unmutated CD19, is reduced by approxi-
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exon 8 through the polyA sequence, was cloned into the AatII sitetion of CD38, but further maturation is required to com-
at the distal end of the pcr fragment. The human cDNA fragment wasplete the germinal center reaction and for production
either from unmutated human CD19 (WT) or from cDNA encodingof Ab.
substitutions for pairs of tyrosines (Y330 and Y360, Y391 and Y421,
The percentage of germinal center B cells that were Y403 and Y443, and Y482 and Y513), replaced with phenylalanine
in S phase was reduced in mice with defective CD19. (Y330F/Y360F, Y391F/Y421F, Y403F/Y443F, and Y482F/Y513F) as
previously described (Brooks et al., 2000). Transgene DNA was in-Keeping in mind that phenotypically normal cells are
jected either into 129Sv/J (WT, Y391F/Y421F, and Y482F/Y513F) orpresent, a slowing of cell cycle would in itself result in
(SJL x B6) F1 (Y330F/Y360F and Y403F/Y443F) blastocysts. Founderreduced expansion at each stage of the germinal center
mice were crossed to 129Sv/J CD19/ mice (Rickert et al., 1995).reaction, and finally in T-dependent Ab responses, in
Handling of mice and experiments were conducted in accordance
the CD19/ and Y482/Y513F mice. Rapid cycling is with institutional policies for animal care and use.
an essential component of the germinal center reac-
tion. Differentiation, somatic hypermutation, and class Cell Phenotype and Histology
FITC anti-CD21, IgG1, IgG2a, IgG2b, IgG3, IgE, IgA, PE anti-CD19,switching have each been linked to the number of cell
CD5, Fas, Mac-1, PerCP anti-B220, and streptavidin-APC were pur-divisions (Hodgkin et al., 1996; Jacob et al., 1993). In
chased from BD Pharmingen. FITC-IgM, FITC, and biotinylated anti-our initial description of the enhancing effect of CD19
IgD and PE-CD23 were from Southern Biotech Associates. FITC-on BCR-dependent proliferation in primary (human) B
labeled PNA was from Vector Laboratory and PE-conjugated NP
cells using a cell-based receptor aggregation system, was from Biosearch Technology. MOMA-1 (rat IgG2a, specific for
not only did CD19 reduce the threshold for induction of mouse splenic metallophilic macrophages) and goat anti-mouse
IgMa RS3.1-Alexa488 were gifts of Dr. John Kearney. Three- andthymidine incorporation, but CD19 also increased DNA
four-color surface staining, flow cytometry, and immunohistochem-synthesis at any concentration of anti-Ig, and including
istry were performed as previously described (Martin and Kearney,a 2-fold enhancement even at maximal concentration
2000a).of anti-Ig (Carter and Fearon, 1992). In experiments such
as that shown in Figure 6, the percentage of Brdu,
Ab Responses
tetraploid cells was increased in mice with defective Mice were immunized with 50 g/100 l of T cell-independent
CD19 function, suggesting a mitotic delay, but CD19 antigen phosphorylcholine (PC)-Ficoll and 2,4,6-trinitrophenyl
(TNP)(6)-Ficoll (Biosearch Technologies) in PBS intraperitoneally. Tcould also alter cell cycle progression by regulation of
cell-dependent antigen response was analyzed by intraperitonealG1 or G2 checkpoints. We propose that this ability of
injections of 50 g/100 l of alum (Pierce) absorbed 4-hydroxy-3-CD19 to enhance cell cycle progression, induced via
nitrophenylacetyl chicken--globulin (NP(21)-CGG) (Biosearchthe BCR, CD40, and cytokines such as IL-4, is the basis
Technologies) or 100 l sheep red blood cell (SRBC, Colorado Se-
for the requirement for CD19 at multiple steps in the rum). Mice immunized with NP-CGG were rechallenged at day 28
germinal center reaction, for which rapid proliferation is with NP-CGG in PBS. Mice were bled before and after immunization,
and the sera were tested for antigen-specific Ab by enzyme-linkedan essential component.
immunosorbent assay (ELISA). PC-specific and TNP-specific AbMarginal zone B cells and B1 cells contain reservoirs
levels were determined by ELISA using microtiter plates coated withof autoreactive B cells that can respond rapidly to anti-
PC-BSA and TNP-BSA (Biosearch Technologies). Serum anti-NP Abgen (Fagarasan and Honjo, 2000; Martin and Kearney,
levels were measured by coating plates with NP(21)-BSA in PBS.
2000b). Germinal center B cells are precursors to Plates were blocked with 200 l 0.5% gelatin in PBS. Duplicate
switched, high-affinity cells, which are characteristic of diluted serum samples were added to individual wells. Bound Ab
was detected by a secondary Ab to mouse IgM, IgG1, or IgG3the autoreactive B cells in patients with rheumatoid ar-
conjugated with horseradish peroxidase (Southern Biotechnologythritis and systemic lupus erythematosus. The marginal
Associates). A pool of sera from immunized CD19/ mice (for IgMzone, B1, and germinal center B cells are all dependent
and IgG3 using serum 7 days postimmunization; for IgG1 usingon CD19 Y482 and Y513. Therapeutic targeting of these
serum 28 days postimmunization) was used as an internal standard
tyrosines may be useful in treating autoimmune dis- set arbitrarily at 10,000 U for IgM and 1,000,000 U for IgG1 and
eases, by eliminating reservoirs of autoreactive marginal IgG3. The standard curves were plotted with arbitrary units and OD
values from serial diluted standard serum, starting from 1:20. Tozone and B1 cells and preventing the generation of high-
compare ELISA plates, the internal standard was added to eachaffinity autoantibodies in germinal centers, without sac-
plate and 1:100 diluted sera from individual test mice were comparedrificing nonresponding follicular mantle cells.
to serial dilutions of this standard. PC-, TNP-, and NP-specific Ab
levels from test mice were expressed in relative units (RU) by com-Experimental Procedures
paring the mean OD values with the standard curves.
Transgenes and Mice
Cell Cycle AnalysisCD19 transgenes were constructed by linking mouse 129Sv/J geno-
Mice were preimmunized with SRBC for 7 days. Brdu given as amic DNA, which spanned from 4.6 kb 5 of the transcription start
1 mg intraperitoneal injection 2–3 hr before spleens were taken forsite through intron 6, with human CD19 cDNA containing exons 7
analysis. Ten million splenocytes were surface-stained with PE anti-to 15 (Figure 1). Polymerase chain reaction (pcr) was used to con-
Fas and processed for staining with the FITC anti-Brdu using Brdustruct a HindIII-AatII fragment, with an upstream oligo that contained
flow kit reagents (Pharmingen) according to the manufacturer’s pro-the sequence of murine CD19 intron 6 distal to the HindIII site,
tocol. The cells were then stained intracellularly with biotinylatedspanned the boundary with exon 7, and then contained the human
F(ab) anti-IgM (Jackson Immunoresearch Laboratory) and strepa-cDNA sequence corresponding to the proximal region of exon 7.
vidin-APC. Finally, cells were stained with 7-aminoactinomycin DThe distal oligo contained the human cDNA sequence proximal to
(7-AAD). Cell cycle was analyzed on a FACS Calibur (Becton Dick-an AatII site in the region corresponding to exon 8. Human CD19
inson).cDNA, either unmutated or containing mutations in the codons for
the proximal tyrosines, was used as a primer. A HindIII- HindIII
genomic fragment of 129Sv/J encoding the 5 upstream and exon B Cell Activation, Immunoprecipitation, Western Blot Analysis
B cells were prepared as previously described (Li et al., 2001). B1–intron 6 of murine genomic CD19 was cloned into the HindIII site
at the proximal end of the pcr product. A fragment of different human cells were stimulated with varying concentrations of F(ab)2 poly-
clonal goat anti-IgM (Jackson ImmunoResearch Laboratories, Inc.)CD19 cDNAs, from the AatII site in the sequence corresponding to
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or F(ab)2 polyclonal rabbit anti-IgG(HL) (Zymed Laboratories Inc.) Fagarasan, S., and Honjo, T. (2000). T-independent immune re-
sponse: new aspects of B cell biology. Science 290, 89–92.in the presence or absence of 1D3 monoclonal rat anti-mouse CD19
or with 10 mM VO4 and 10 M H2O2. If whole Ab was used, splenic Fearon, D.T., and Carroll, M.C. (2000). Regulation of B lymphocyte
B cells, at 2  107 cells/ml in PBS, were preincubated with 5 g/ responses to foreign and self-antigens by the CD19/CD21 complex.
ml FcR Block (anti-CD16/CD32, Pharmingen) for 10 min at room Annu. Rev. Immunol. 18, 393–422.
temperature. Lysis, immunoprecipitation, and immunoblotting were
Fruman, D.A., Snapper, S.B., Yballe, C.M., Davidson, L., Yu, J.Y.,as previously described (Li et al., 2001). Polyclonal rabbit anti-CD19
Alt, F.W., and Cantley, L.C. (1999). Impaired B cell development andAb was made using a fusion protein containing the cytoplasmic
proliferation in absence of Phosphoinositide 3-kinase p85	. Scienceportion of human CD19.
283, 393–397.
Fujimoto, M., Poe, J.C., Inaoki, M., and Tedder, T.F. (1998). CD19Intracellular Free Calcium Concentration
regulates B lymphocyte responses to transmembrane signals.Purified B cells were loaded at 37C with 4 M of Fluo-4-acetoxy-
Semin. Immunol. 10, 267–277.methyl ester and 2 M SNARF-1-acetoxymethyl ester for 40 min
as per the manufacturer’s protocol (Molecular Probes). Cells were Fujimoto, M., Poe, J.C., Jansen, P.J., Sato, S., and Tedder, T.F.
analyzed by flow cytometry for changes in Fluo-4 and SNARF-1 (1999). CD19 amplifies B lymphocyte signal transduction by regulat-
fluorescences were monitored by flow cytometry (FACS Calibur, ing Src-family protein tyrosine kinase activation. J. Immunol. 162,
Becton Dickinson). After a 20 s baseline, stimulation Ab was added, 7088–7094.
and analysis continued for a total of 7 min. Data were collected using Fujimoto, M., Fujimoto, Y., Poe, J., Jansen, P., Lowell, C., DeFranco,
a two-dimensional plot to display the Fluo-4 (520 nm)/SNARF-1 (580 A., and Tedder, T. (2000). CD19 regulates Src family protein tyrosine
nm) ratio as a function of time. kinase activation in B lymphocytes through processive amplifica-
tion. Immunity 13, 46–57.
Replication Fujimoto, M., Poe, J.C., Hasegawa, M., and Tedder, T.F. (2001).
All results were replicated at least twice. CD19 amplification of B lymphocyte Ca2 responses: a role for Lyn
sequestration in extinguishing negative regulation. J. Biol. Chem.
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